Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $108.21 billion. The enterprise value is $118.57 billion.
| Market Cap | 108.21B |
| Enterprise Value | 118.57B |
Important Dates
The next confirmed earnings date is Thursday, April 25, 2024, before market open.
| Earnings Date | Apr 25, 2024 |
| Ex-Dividend Date | May 9, 2024 |
Share Statistics
Sanofi has 2.34 billion shares outstanding. The number of shares has decreased by -0.12% in one year.
| Shares Outstanding | 2.34B |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 9.94% |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 19.91 and the forward PE ratio is 11.14. Sanofi's PEG ratio is 0.84.
| PE Ratio | 19.91 |
| Forward PE | 11.14 |
| PS Ratio | 2.10 |
| Forward PS | 2.28 |
| PB Ratio | 1.37 |
| P/FCF Ratio | 12.30 |
| PEG Ratio | 0.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.48, with an EV/FCF ratio of 13.48.
| EV / Earnings | 19.76 |
| EV / Sales | 2.30 |
| EV / EBITDA | 8.48 |
| EV / EBIT | 13.37 |
| EV / FCF | 13.48 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.27 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.41 |
| Debt / FCF | 2.23 |
| Interest Coverage | 6.33 |
Financial Efficiency
Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 6.57%.
| Return on Equity (ROE) | 7.30% |
| Return on Assets (ROA) | 4.30% |
| Return on Capital (ROIC) | 6.57% |
| Revenue Per Employee | $599,438 |
| Profits Per Employee | $69,696 |
| Employee Count | 86,088 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, Sanofi has paid $1.71 billion in taxes.
| Income Tax | 1.71B |
| Effective Tax Rate | 22.16% |
Stock Price Statistics
The stock price has decreased by -16.91% in the last 52 weeks. The beta is 0.45, so Sanofi's price volatility has been lower than the market average.
| Beta (1Y) | 0.45 |
| 52-Week Price Change | -16.91% |
| 50-Day Moving Average | 47.49 |
| 200-Day Moving Average | 50.07 |
| Relative Strength Index (RSI) | 42.69 |
| Average Volume (30 Days) | 1,963,164 |
Short Selling Information
| Short Interest | 3.90M |
| Short Previous Month | 4.59M |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 2.34 |
Income Statement
In the last 12 months, Sanofi had revenue of $51.60 billion and earned $6.00 billion in profits. Earnings per share was $2.29.
| Revenue | 51.60B |
| Gross Profit | 34.34B |
| Operating Income | 8.40B |
| Pretax Income | 7.47B |
| Net Income | 6.00B |
| EBITDA | 13.98B |
| EBIT | 8.87B |
| Earnings Per Share (EPS) | $2.29 |
Balance Sheet
The company has $9.29 billion in cash and $19.64 billion in debt, giving a net cash position of -$10.36 billion or -$4.43 per share.
| Cash & Cash Equivalents | 9.29B |
| Total Debt | 19.64B |
| Net Cash | -10.36B |
| Net Cash Per Share | -$4.43 |
| Equity / Book Value | 78.95B |
| Book Value Per Share | 33.78 |
| Working Capital | 6.89B |
Cash Flow
In the last 12 months, operating cash flow was $10.94 billion and capital expenditures -$2.14 billion, giving a free cash flow of $8.80 billion.
| Operating Cash Flow | 10.94B |
| Capital Expenditures | -2.14B |
| Free Cash Flow | 8.80B |
| FCF Per Share | $3.51 |
Margins
Gross margin is 66.55%, with operating and profit margins of 16.27% and 11.63%.
| Gross Margin | 66.55% |
| Operating Margin | 16.27% |
| Pretax Margin | 14.47% |
| Profit Margin | 11.63% |
| EBITDA Margin | 27.08% |
| EBIT Margin | 17.18% |
| FCF Margin | 17.04% |
Dividends & Yields
This stock pays an annual dividend of $2.04, which amounts to a dividend yield of 4.40%.
| Dividend Per Share | $2.04 |
| Dividend Yield | 4.40% |
| Dividend Growth (YoY) | 7.22% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 89.24% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 4.52% |
| Earnings Yield | 5.54% |
| FCF Yield | 8.13% |
Analyst Forecast
The average price target for Sanofi is $55.00, which is 18.79% higher than the current price. The consensus rating is "Hold".
| Price Target | $55.00 |
| Price Target Difference | 18.79% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 4.03% |
| EPS Growth Forecast (5Y) | 38.97% |
Stock Splits
The last stock split was on September 30, 2013. It was a forward split with a ratio of 5:1.
| Last Split Date | Sep 30, 2013 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |